The effects of diazepam, clomipramine, and chlorpromazine upon cerebral metabolism and blood flow were examined separately in 18 dogs. After the administration of diazepam or clomipramine, cerebral cortical oxygen consumption (CMRO2) decreased significantly by a maximum of 17% and 13% of control within 10 minutes and 15 minutes, and returned to control at 120 minutes and 90 minutes, respectively. Chlorpromazine, however, decreased by a maximum of 10% of control, a level which continued throughout the period of observation. It was observed that reduction in CMRglucose was followed by the reduction in CMRO2 at an interval during the early stages of CMRO2 depression. Diazepam produced a significant decrease in CBF accompanied by a reduction in CMRO2, but neither clomipramine nor chlorpromazine had any effect on CBF in spite of reduction in CMRO2. Reduction in CMRO2 both with diazepam and clomipramine was accompanied by slow wave activities of EEG, but with chlorpromazine reduction in CMR02 was accompanied with less pronounced slow wave activities. It was concluded that the three drugs examined were cerebral metabolic depressants.
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It has been generally assumed that the effects of psychotropic drugs upon the central nervous system are related to their therapeutic action in patients with psychiatric disorder. This assumption follows from extensive pharmacological, biochemical, and electrophysiological studies obtained with these drugs. In the present study we examined the effect of three psychotropic drugs-diazepam, clomipramine, and chlorpromazine-on the canine cerebral metabolism and circulation.
Although the effects of chlorpromazine on cerebral oxygen consumption have been extensively investigated in animals (Frowein et al., 1955) or men (Fazekas et al., 1955; Morris et al., 1955; Aizawa et al., 1956; Moyer et al., 1956; Ehrmantraut et al., 1957; Sutherland et al., for blood sampling and pressure determination, in one femoral vein for the reinfusion of blood, and in another femoral vein for drug administration. Thereafter, the dog was placed in a prone position with the head supported on a block. The surgical preparation used in the present study for direct measurement of cerebral blood flow (CBF) was originally described in detail by Cohen et al. (1967) . The EEG was recorded from the parietal lobes using bipolar silver-silver chloride disc electrodes and was analysed every 10 seconds with a frequency analyser, MAF-5 (Nihonkoden, Tokyo, Japan) throughout the study. Every (Fig. 3) . These EEG changes with clomipramine gradually returned to control levels within 90 to 120 minutes after injection. Chlorpromazine showed different EEG changes from the two former drugs; significant increases in 8 and a wave activities were observed from 30 minutes and 10 minutes after injection, respectively, accompanied by a significant reduction in fl2 waves (Fig. 4) Cassano et al. (1965) demonstrated the distribution of chlorpromazine in cat brain using an autoradiographic technique and showed that retention of this agent in the cortex was reduced four hours later. Although many of the reports cited above are contrary to our findings, a possible explanation for this discrepancy could be the difference in the methods used for measuring CBF. The above-mentioned studies determined CBF by the nitrous oxide method of Kety and Schmidt (1948) , while, in our study, CBF was determined by the direct measurement method described originally by Michenfelder et al. (1968) . Theye and Michenfelder (1968) This was also suggestive in the chlorpromazine group at 10 minutes. Our findings showed that the changes in CMRgIucOse were slower than those of CMRO2 at early states of their alteration. This delayed change in CMRglu0ose was probably due to differences in equilibration of oxygen and glucose metabolism. Chlorpromazine produced a significant increase in CMRglucose at five minutes. Aizawa et al. (1956) found an increase in CMRglucose 30 minutes after injection of chlorpromazine in man that was probably due to a rise in glucose level in the blood, but the blood glucose level was not mentioned. In the present study, a transitory but significant increase in CMRglucose was not accompanied by an elevated blood glucose level. This finding is contrary to previous reports (Norman and Hiestand, 1955; Ryall, 1956; Bonaccorsi et al., 1964; Bachelard and Lindsay, 1966) , which suggest hyperglycaemia with this drug. However, Norman and Hiestand (1955) found a profound species variation in hyperglycaemic response to chlorpromazine. At the present, it is difficult to evaluate the significance of the increase in CMRglucose with chlorpromazine. Changes in CMRO2 were paralleled by slow wave activities in the EEG (Fig. 1) 
